List of Tables
Table 1 Oral Proteins & Peptides Market: Impact Analysis
Table 2 Oral Proteins & Peptides Market: Role of Raw Material Vendors
Table 3 Oral Proteins & Peptides Market: Role of Product Providers
Table 4 Oral Proteins & Peptides Market: Role of End-users
Table 5 Oral Proteins & Peptides Market: Role of Regulatory Authorities
Table 6 Oral Proteins & Peptides Market: Porter's Five Forces Analysis
Table 7 Buying Criteria for Oral Proteins & Peptides, by End-user
Table 8 Pricing Analysis, by Product, 2024
Table 9 Pricing Analysis, by Country and Region (USD), 2024
Table 10 Regulatory Scenario for Oral Proteins & Peptides Market
Table 11 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Oral Peptides in Clinical Pipeline (As of August 2024)
Table 16 Oral Proteins & Peptides Market: Top 20 Patent Owners, 2014-2024
Table 17 Indicative List of Patents in Oral Proteins & Peptides Market, 2022-2024
Table 18 Oral Proteins & Peptides Market: Detailed List of Conferences & Events
Table 19 Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 20 Semaglutide Market, by Region, 2022-2029 (USD Million)
Table 21 North America: Semaglutide Market, by Country, 2022-2029 (USD Million)
Table 22 Europe: Semaglutide Market, by Country, 2022-2029 (USD Million)
Table 23 Asia-Pacific: Semaglutide Market, by Country, 2022-2029 (USD Million)
Table 24 Latin America: Semaglutide Market, by Country, 2022-2029 (USD Million)
Table 25 Middle East: Semaglutide Market, by Region, 2022-2029 (USD Million)
Table 26 GCC Countries: Semaglutide Market, by Country, 2022-2029 (USD Million)
Table 27 Calcitonin Market, by Region, 2022-2029 (USD Million)
Table 28 North America: Calcitonin Market, by Country, 2022-2029 (USD Million)
Table 29 Europe: Calcitonin Market, by Country, 2022-2029 (USD Million)
Table 30 Asia-Pacific: Calcitonin Market, by Country, 2022-2029 (USD Million)
Table 31 Latin America: Calcitonin Market, by Country, 2022-2029 (USD Million)
Table 32 Middle East: Calcitonin Market, by Region, 2022-2029 (USD Million)
Table 33 GCC Countries: Calcitonin Market, by Country, 2022-2029 (USD Million)
Table 34 Linaclotide Market, by Region, 2022-2029 (USD Million)
Table 35 North America: Linaclotide Market, by Country, 2022-2029 (USD Million)
Table 36 Europe: Linaclotide Market, by Country, 2022-2029 (USD Million)
Table 37 Asia-Pacific: Linaclotide Market, by Country, 2022-2029 (USD Million)
Table 38 Latin America: Linaclotide Market, by Country, 2022-2029 (USD Million)
Table 39 Middle East: Linaclotide Market, by Region, 2022-2029 (USD Million)
Table 40 GCC Countries: Linaclotide Market, by Country, 2022-2029 (USD Million)
Table 41 Trofinetide Market, by Region, 2022-2029 (USD Million)
Table 42 North America: Trofinetide Market, by Country, 2022-2029 (USD Million)
Table 43 Europe: Trofinetide Market, by Country, 2022-2029 (USD Million)
Table 44 Asia-Pacific: Trofinetide Market, by Country, 2022-2029 (USD Million)
Table 45 Latin America: Trofinetide Market, by Country, 2022-2029 (USD Million)
Table 46 Middle East: Trofinetide Market, by Region, 2022-2029 (USD Million)
Table 47 GCC Countries: Trofinetide Market, by Country, 2022-2029 (USD Million)
Table 48 Voclosporin Market, by Region, 2022-2029 (USD Million)
Table 49 North America: Voclosporin Market, by Country, 2022-2029 (USD Million)
Table 50 Europe: Voclosporin Market, by Country, 2022-2029 (USD Million)
Table 51 Asia-Pacific: Voclosporin Market, by Country, 2022-2029 (USD Million)
Table 52 Plecanatide Market, by Region, 2022-2029 (USD Million)
Table 53 North America: Plecanatide Market, by Country, 2022-2029 (USD Million)
Table 54 Europe: Plecanatide Market, by Country, 2022-2029 (USD Million)
Table 55 Asia-Pacific: Plecanatide Market, by Country, 2022-2029 (USD Million)
Table 56 Latin America: Plecanatide Market, by Country, 2022-2029 (USD Million)
Table 57 Middle East: Plecanatide Market, by Region, 2022-2029 (USD Million)
Table 58 GCC Countries: Plecanatide Market, by Country, 2022-2029 (USD Million)
Table 59 Other Oral Protein & Peptide Molecules Market, by Region, 2022-2029 (USD Million)
Table 60 North America: Other Oral Protein & Peptide Molecules Market, By Country, 2022-2029 (USD Million)
Table 61 Europe: Other Oral Protein & Peptide Molecules Market, By Country, 2022-2029 (USD Million)
Table 62 Asia-Pacific: Other Oral Protein & Peptide Molecules Market, By Country, 2022-2029 (USD Million)
Table 63 Latin America: Other Oral Protein & Peptide Molecules Market, By Country, 2022-2029 (USD Million)
Table 64 Middle East: Other Oral Protein & Peptide Molecules Market, By Region, 2022-2029 (USD Million)
Table 65 GCC Countries: Other Oral Protein & Peptide Molecules Market, By Country, 2022-2029 (USD Million)
Table 66 Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 67 Glp-1 Receptor Agonists Market, by Region, 2022-2029 (USD Million)
Table 68 North America: Glp-1 Receptor Agonists Market, by Country, 2022-2029 (USD Million)
Table 69 Europe: Glp-1 Receptor Agonists Market, by Country, 2022-2029 (USD Million)
Table 70 Asia-Pacific: Glp-1 Receptor Agonists Market, by Country, 2022-2029 (USD Million)
Table 71 Latin America: Glp-1 Receptor Agonists Market, by Country, 2022-2029 (USD Million)
Table 72 Middle East: Glp-1 Receptor Agonists Market, by Region, 2022-2029 (USD Million)
Table 73 GCC Countries: Glp-1 Receptor Agonists Market, by Country, 2022-2029 (USD Million)
Table 74 Cgrp Receptor Antagonists Market, by Region, 2022-2029 (USD Million)
Table 75 North America: Cgrp Receptor Antagonists Market, by Country, 2022-2029 (USD Million)
Table 76 Europe: Cgrp Receptor Antagonists Market, by Country, 2022-2029 (USD Million)
Table 77 Asia-Pacific: Cgrp Receptor Antagonists Market, by Country, 2022-2029 (USD Million)
Table 78 Latin America: Cgrp Receptor Antagonists Market, by Country, 2022-2029 (USD Million)
Table 79 Middle East: Cgrp Receptor Antagonists Market, by Region, 2022-2029 (USD Million)
Table 80 GCC Countries: Cgrp Receptor Antagonists Market, by Country, 2022-2029 (USD Million)
Table 81 Gc-C Agonists Market, by Region, 2022-2029 (USD Million)
Table 82 North America: Gc-C Agonists Market, by Country, 2022-2029 (USD Million)
Table 83 Europe: Gc-C Agonists Market, by Country, 2022-2029 (USD Million)
Table 84 Asia-Pacific: Gc-C Agonists Market, by Country, 2022-2029 (USD Million)
Table 85 Latin America: Gc-C Agonists Market, by Country, 2022-2029 (USD Million)
Table 86 Middle East: Gc-C Agonists Market, by Region, 2022-2029 (USD Million)
Table 87 GCC Countries: Gc-C Agonists Market, by Country, 2022-2029 (USD Million)
Table 88 Gpe Market, by Region, 2022-2029 (USD Million)
Table 89 North America: Gpe Market, by Country, 2022-2029 (USD Million)
Table 90 Europe: Gpe Market, by Country, 2022-2029 (USD Million)
Table 91 Asia-Pacific: Gpe Market, by Country, 2022-2029 (USD Million)
Table 92 Latin America: Gpe Market, by Country, 2022-2029 (USD Million)
Table 93 Middle East: Gpe Market, by Region, 2022-2029 (USD Million)
Table 94 GCC Countries: Gpe Market, by Country, 2022-2029 (USD Million)
Table 95 Cni Market, by Region, 2022-2029 (USD Million)
Table 96 North America: Cni Market, by Country, 2022-2029 (USD Million)
Table 97 Europe: Cni Market, by Country, 2022-2029 (USD Million)
Table 98 Asia-Pacific: Cni Market, by Country, 2022-2029 (USD Million)
Table 99 Other Oral Protein & Peptide Drug Classes Market, By Region, 2022-2029 (USD Million)
Table 100 North America: Other Oral Protein & Peptide Drug Classes Market, By Country, 2022-2029 (USD Million)
Table 101 Europe: Other Oral Protein & Peptide Drug Classes Market, By Country, 2022-2029 (USD Million)
Table 102 Asia-Pacific: Other Oral Protein & Peptide Drug Classes Market, By Country, 2022-2029 (USD Million)
Table 103 Latin America: Other Oral Protein & Peptide Drug Classes Market, By Country, 2022-2029 (USD Million)
Table 104 Middle East: Other Oral Protein & Peptide Drug Classes Market, By Region, 2022-2029 (USD Million)
Table 105 GCC Countries: Other Oral Protein & Peptide Drug Classes Market, By Country, 2022-2029 (USD Million)
Table 106 Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 107 Oral Proteins & Peptides Market for Diabetes, by Region, 2022-2029 (USD Million)
Table 108 North America: Oral Proteins & Peptides Market for Diabetes, By Country, 2022-2029 (USD Million)
Table 109 Europe: Oral Proteins & Peptides Market for Diabetes, By Country, 2022-2029 (USD Million)
Table 110 Asia-Pacific: Oral Proteins & Peptides Market for Diabetes, By Country, 2022-2029 (USD Million)
Table 111 Latin America: Oral Proteins & Peptides Market for Diabetes, By Country, 2022-2029 (USD Million)
Table 112 Middle East: Oral Proteins & Peptides Market for Diabetes, By Country, 2022-2029 (USD Million)
Table 113 GCC Countries: Oral Proteins & Peptides Market for Diabetes, By Country, 2022-2029 (USD Million)
Table 114 Oral Proteins & Peptides Market for Cns Disorders, by Region, 2022-2029 (USD Million)
Table 115 North America: Oral Proteins & Peptides Market for Cns Disorders, By Country, 2022-2029 (USD Million)
Table 116 Europe: Oral Proteins & Peptides Market for Cns Disorders, By Country, 2022-2029 (USD Million)
Table 117 Asia-Pacific: Oral Proteins & Peptides Market for Cns Disorders, By Country, 2022-2029 (USD Million)
Table 118 Latin America: Oral Proteins & Peptides Market for Cns Disorders, By Country, 2022-2029 (USD Million)
Table 119 Middle East: Oral Proteins & Peptides Market for Cns Disorders, By Country, 2022-2029 (USD Million)
Table 120 GCC Countries: Oral Proteins & Peptides Market for Cns Disorders, By Country, 2022-2029 (USD Million)
Table 121 Oral Proteins & Peptides Market for Gastroenterology, By Region, 2022-2029 (USD Million)
Table 122 North America: Oral Proteins & Peptides Market for Gastroenterology, by Country, 2022-2029 (USD Million)
Table 123 Europe: Oral Proteins & Peptides Market for Gastroenterology, By Country, 2022-2029 (USD Million)
Table 124 Asia-Pacific: Oral Proteins & Peptides Market for Gastroenterology, By Country, 2022-2029 (USD Million)
Table 125 Latin America: Oral Proteins & Peptides Market for Gastroenterology, by Country, 2022-2029 (USD Million)
Table 126 Middle East: Oral Proteins & Peptides Market for Gastroenterology, by Country, 2022-2029 (USD Million)
Table 127 GCC Countries: Oral Proteins & Peptides Market for Gastroenterology, by Country, 2022-2029 (USD Million)
Table 128 Oral Proteins & Peptides Market for Genetic Disorders, by Region, 2022-2029 (USD Million)
Table 129 North America: Oral Proteins & Peptides Market for Genetic Disorders, by Country, 2022-2029 (USD Million)
Table 130 Europe: Oral Proteins & Peptides Market for Genetic Disorders, By Country, 2022-2029 (USD Million)
Table 131 Asia-Pacific: Oral Proteins & Peptides Market for Genetic Disorders, By Country, 2022-2029 (USD Million)
Table 132 Latin America: Oral Proteins & Peptides Market for Genetic Disorders, by Country, 2022-2029 (USD Million)
Table 133 Middle East: Oral Proteins & Peptides Market for Genetic Disorders, by Region, 2022-2029 (USD Million)
Table 134 GCC Countries: Oral Proteins & Peptides Market for Genetic Disorders, by Country, 2022-2029 (USD Million)
Table 135 Oral Proteins & Peptides Market for Nephrology, by Region, 2022-2029 (USD Million)
Table 136 North America: Oral Proteins & Peptides Market for Nephrology, By Country, 2022-2029 (USD Million)
Table 137 Europe: Oral Proteins & Peptides Market for Nephrology, By Country, 2022-2029 (USD Million)
Table 138 Asia-Pacific: Oral Proteins & Peptides Market for Nephrology, By Country, 2022-2029 (USD Million)
Table 139 Oral Proteins & Peptides Market for Obesity & Overweight, by Region, 2022-2029 (USD Million)
Table 140 North America: Oral Proteins & Peptides Market for Obesity & Overweight, by Country, 2022-2029 (USD Million)
Table 141 Europe: Oral Proteins & Peptides Market for Obesity & Overweight, By Country, 2022-2029 (USD Million)
Table 142 Asia-Pacific: Oral Proteins & Peptides Market for Obesity & Overweight, by Country, 2022-2029 (USD Million)
Table 143 Oral Proteins & Peptides Market for Other Therapeutic Areas, By Region, 2022-2029 (USD Million)
Table 144 North America: Oral Proteins & Peptides Market for Other Therapeutic Areas, by Country, 2022-2029 (USD Million)
Table 145 Europe: Oral Proteins & Peptides Market for Other Therapeutic Areas, by Country, 2022-2029 (USD Million)
Table 146 Asia-Pacific: Oral Proteins & Peptides Market for Other Therapeutic Areas, by Country, 2022-2029 (USD Million)
Table 147 Latin America: Oral Proteins & Peptides Market for Other Therapeutic Areas, by Country, 2022-2029 (USD Million)
Table 148 Middle East: Oral Proteins & Peptides Market for Other Therapeutic Areas, by Country, 2022-2029 (USD Million)
Table 149 GCC Countries: Oral Proteins & Peptides Market for Other Therapeutic Areas, by Country, 2022-2029 (USD Million)
Table 150 Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 151 Oral Protein & Peptide Tablets Market, by Region, 2022-2029 (USD Million)
Table 152 North America: Oral Protein & Peptide Tablets Market, By Country, 2022-2029 (USD Million)
Table 153 Europe: Oral Protein & Peptide Tablets Market, by Country, 2022-2029 (USD Million)
Table 154 Asia-Pacific: Oral Protein & Peptide Tablets Market, by Country, 2022-2029 (USD Million)
Table 155 Latin America: Oral Protein & Peptide Tablets Market, by Country, 2022-2029 (USD Million)
Table 156 Middle East: Oral Protein & Peptide Tablets Market, by Country, 2022-2029 (USD Million)
Table 157 GCC Countries: Oral Protein & Peptide Tablets Market, by Country, 2022-2029 (USD Million)
Table 158 Oral Protein & Peptide Capsules Market, by Region, 2022-2029 (USD Million)
Table 159 North America: Oral Protein & Peptide Capsules Market, By Country, 2022-2029 (USD Million)
Table 160 Europe: Oral Protein & Peptide Capsules Market, by Country, 2022-2029 (USD Million)
Table 161 Asia-Pacific: Oral Protein & Peptide Capsules Market, by Country, 2022-2029 (USD Million)
Table 162 Latin America: Oral Protein & Peptide Capsules Market, By Country, 2022-2029 (USD Million)
Table 163 Middle East: Oral Protein & Peptide Capsules Market, By Country, 2022-2029 (USD Million)
Table 164 GCC Countries: Oral Protein & Peptide Capsules Market, By Country, 2022-2029 (USD Million)
Table 165 Oral Protein & Peptide Solutions Market, by Region, 2022-2029 (USD Million)
Table 166 North America: Oral Protein & Peptide Solutions Market, By Country, 2022-2029 (USD Million)
Table 167 Europe: Oral Protein & Peptide Solutions Market, by Country, 2022-2029 (USD Million)
Table 168 Asia-Pacific: Oral Protein & Peptide Solutions Market, By Country, 2022-2029 (USD Million)
Table 169 Latin America: Oral Protein & Peptide Solutions Market, By Country, 2022-2029 (USD Million)
Table 170 Middle East: Oral Protein & Peptide Solutions Market, By Country, 2022-2029 (USD Million)
Table 171 GCC Countries: Oral Protein & Peptide Solutions Market, By Country, 2022-2029 (USD Million)
Table 172 Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 173 Oral Proteins & Peptides Market for Home Care Settings, By Region, 2022-2029 (USD Million)
Table 174 North America: Oral Proteins & Peptides Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 175 Europe: Oral Proteins & Peptides Market for Home Care Settings, By Country, 2022-2029 (USD Million)
Table 176 Asia-Pacific: Oral Proteins & Peptides Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 177 Latin America: Oral Proteins & Peptides Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 178 Middle East: Oral Proteins & Peptides Market for Home Care Settings, by Region, 2022-2029 (USD Million)
Table 179 GCC Countries: Oral Proteins & Peptides Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 180 Oral Proteins & Peptides Market for Long-Term Care Facilities, By Region, 2022-2029 (USD Million)
Table 181 North America: Oral Proteins & Peptides Market for Long-Term Care Facilities, by Country, 2022-2029 (USD Million)
Table 182 Europe: Oral Proteins & Peptides Market for Long-Term Care Facilities, by Country, 2022-2029 (USD Million)
Table 183 Asia-Pacific: Oral Proteins & Peptides Market for Long-Term Care Facilities, by Country, 2022-2029 (USD Million)
Table 184 Latin America: Oral Proteins & Peptides Market for Long-Term Care Facilities, by Country, 2022-2029 (USD Million)
Table 185 Middle East: Oral Proteins & Peptides Market for Long-Term Care Facilities, by Region, 2022-2029 (USD Million)
Table 186 GCC Countries: Oral Proteins & Peptides Market for Long-Term Care Facilities, by Country, 2022-2029 (USD Million)
Table 187 Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, By Region, 2022-2029 (USD Million)
Table 188 North America: Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, by Country, 2022-2029 (USD Million)
Table 189 Europe: Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, by Country, 2022-2029 (USD Million)
Table 190 Asia-Pacific: Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, by Country, 2022-2029 (USD Million)
Table 191 Latin America: Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, by Country, 2022-2029 (USD Million)
Table 192 Middle East: Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, by Region, 2022-2029 (USD Million)
Table 193 GCC Countries: Oral Proteins & Peptides Market for Hospitals & Specialty Clinics, by Country, 2022-2029 (USD Million)
Table 194 Oral Proteins & Peptides Market, by Region, 2022-2029 (USD Million)
Table 195 North America: Macroeconomic Outlook
Table 196 North America: Oral Proteins & Peptides Market, by Country, 2022-2029 (USD Million)
Table 197 North America: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 198 North America: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 199 North America: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 200 North America: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 201 North America: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 202 US: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 203 US: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 204 US: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 205 US: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 206 US: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 207 Canada: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 208 Canada: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 209 Canada: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 210 Canada: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 211 Canada: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 212 Europe: Macroeconomic Outlook
Table 213 Europe: Oral Proteins & Peptides Market, by Country, 2022-2029 (USD Million)
Table 214 Europe: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 215 Europe: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 216 Europe: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 217 Europe: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 218 Europe: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 219 Germany: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 220 Germany: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 221 Germany: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 222 Germany: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 223 Germany: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 224 UK: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 225 UK: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 226 UK: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 227 UK: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 228 UK: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 229 France: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 230 France: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 231 France: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 232 France: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 233 France: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 234 Italy: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 235 Italy: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 236 Italy: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 237 Italy: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 238 Italy: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 239 Spain: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 240 Spain: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 241 Spain: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 242 Spain: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 243 Spain: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 244 Netherlands: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 245 Netherlands: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 246 Netherlands: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 247 Netherlands: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 248 Netherlands: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 249 Rest of Europe: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 250 Rest of Europe: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 251 Rest of Europe: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 252 Rest of Europe: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 253 Rest of Europe: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 254 Asia-Pacific: Macroeconomic Outlook
Table 255 Asia-Pacific: Oral Proteins & Peptides Market, by Country, 2022-2029 (USD Million)
Table 256 Asia-Pacific: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 257 Asia-Pacific: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 258 Asia-Pacific: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 259 Asia-Pacific: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 260 Asia-Pacific: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 261 China: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 262 China: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 263 China: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 264 China: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 265 China: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 266 Japan: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 267 Japan: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 268 Japan: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 269 Japan: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 270 Japan: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 271 India: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 272 India: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 273 India: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 274 India: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 275 India: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 276 Australia: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 277 Australia: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 278 Australia: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 279 Australia: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 280 Australia: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 281 South Korea: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 282 South Korea: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 283 South Korea: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 284 South Korea: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 285 South Korea: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 286 Rest of Asia-Pacific: Oral Proteins & Peptides Market, By Molecule, 2022-2029 (USD Million)
Table 287 Rest of Asia-Pacific: Oral Proteins & Peptides Market, By Drug Class, 2022-2029 (USD Million)
Table 288 Rest of Asia-Pacific: Oral Proteins & Peptides Market, By Therapeutic Area, 2022-2029 (USD Million)
Table 289 Rest of Asia-Pacific: Oral Proteins & Peptides Market, By Formulation, 2022-2029 (USD Million)
Table 290 Rest of Asia-Pacific: Oral Proteins & Peptides Market, By End-user, 2022-2029 (USD Million)
Table 291 Latin America: Macroeconomic Outlook
Table 292 Latin America: Oral Proteins & Peptides Market, by Country, 2022-2029 (USD Million)
Table 293 Latin America: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 294 Latin America: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 295 Latin America: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 296 Latin America: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 297 Latin America: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 298 Brazil: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 299 Brazil: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 300 Brazil: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 301 Brazil: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 302 Brazil: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 303 Mexico: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 304 Mexico: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 305 Mexico: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 306 Mexico: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 307 Mexico: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 308 Rest of Latin America: Oral Proteins & Peptides Market, By Molecule, 2022-2029 (USD Million)
Table 309 Rest of Latin America: Oral Proteins & Peptides Market, By Drug Class, 2022-2029 (USD Million)
Table 310 Rest of Latin America: Oral Proteins & Peptides Market, By Therapeutic Area, 2022-2029 (USD Million)
Table 311 Rest of Latin America: Oral Proteins & Peptides Market, By Formulation, 2022-2029 (USD Million)
Table 312 Rest of Latin America: Oral Proteins & Peptides Market, By End-user, 2022-2029 (USD Million)
Table 313 Middle East: Macroeconomic Outlook
Table 314 Middle East: Oral Proteins & Peptides Market, by Country, 2022-2029 (USD Million)
Table 315 Middle East: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 316 Middle East: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 317 Middle East: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 318 Middle East: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 319 Middle East: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 320 GCC Countries: Oral Proteins & Peptides Market, by Region, 2022-2029 (USD Million)
Table 321 GCC Countries: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 322 GCC Countries: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 323 GCC Countries: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 324 GCC Countries: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 325 GCC Countries: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 326 Saudi Arabia: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 327 Saudi Arabia: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 328 Saudi Arabia: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 329 Saudi Arabia: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 330 Saudi Arabia: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 331 UAE: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 332 UAE: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 333 UAE: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 334 UAE: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 335 UAE: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 336 Rest of GCC Countries: Oral Proteins & Peptides Market, By Molecule, 2022-2029 (USD Million)
Table 337 Rest of GCC Countries: Oral Proteins & Peptides Market, By Drug Class, 2022-2029 (USD Million)
Table 338 Rest of GCC Countries: Oral Proteins & Peptides Market, By Therapeutic Area, 2022-2029 (USD Million)
Table 339 Rest of GCC Countries: Oral Proteins & Peptides Market, By Formulation, 2022-2029 (USD Million)
Table 340 Rest of GCC Countries: Oral Proteins & Peptides Market, By End-user, 2022-2029 (USD Million)
Table 341 Rest of Middle East: Oral Proteins & Peptides Market, By Molecule, 2022-2029 (USD Million)
Table 342 Rest of Middle East: Oral Proteins & Peptides Market, By Drug Class, 2022-2029 (USD Million)
Table 343 Rest of Middle East: Oral Proteins & Peptides Market, By Therapeutic Area, 2022-2029 (USD Million)
Table 344 Rest of Middle East: Oral Proteins & Peptides Market, By Formulation, 2022-2029 (USD Million)
Table 345 Rest of Middle East: Oral Proteins & Peptides Market, By End-user, 2022-2029 (USD Million)
Table 346 Africa: Macroeconomic Outlook
Table 347 Africa: Oral Proteins & Peptides Market, by Molecule, 2022-2029 (USD Million)
Table 348 Africa: Oral Proteins & Peptides Market, by Drug Class, 2022-2029 (USD Million)
Table 349 Africa: Oral Proteins & Peptides Market, by Therapeutic Area, 2022-2029 (USD Million)
Table 350 Africa: Oral Proteins & Peptides Market, by Formulation, 2022-2029 (USD Million)
Table 351 Africa: Oral Proteins & Peptides Market, by End-user, 2022-2029 (USD Million)
Table 352 Overview of Strategies Deployed by Key Players in Oral Proteins & Peptides Market
Table 353 Oral Proteins & Peptides Market: Degree of Competition
Table 354 Oral Proteins & Peptides Market: Molecule Footprint (Key Players)
Table 355 Oral Proteins & Peptides Market: Formulation Footprint (Key Players)
Table 356 Oral Proteins & Peptides Market: Therapeutic Area Footprint (Key Players)
Table 357 Oral Proteins & Peptides Market: Therapeutic Area Footprint (Players with Products in Pipeline)
Table 358 Oral Proteins & Peptides Market: Region Footprint (Key Players)
Table 359 Oral Proteins & Peptides Market: Region Footprint (Players with Products in Pipeline)
Table 360 Oral Proteins & Peptides Market: Key Startups/SMEs
Table 361 Oral Proteins & Peptides Market: Competitive Benchmarking Of Key Emerging Players/Startups
Table 362 Oral Proteins & Peptides Market: Product Approvals, January 2021- August 2024
Table 363 Oral Proteins & Peptides Market: Deals, January 2021-August 2024
Table 364 Oral Proteins & Peptides Market: Expansions, January 2021- August 2024
Table 365 Oral Proteins & Peptides Market: Other Developments, January 2021- August 2024
Table 366 Novo Nordisk: Company Overview
Table 367 Novo Nordisk: Products Offered
Table 368 Novo Nordisk: Product Launches & Approvals, January 2021- August 2024
Table 369 Novo Nordisk: Expansions, January 2021- August 2024
Table 370 Novo Nordisk: Other Developments, January 2021- August 2024
Table 371 Abbvie: Company Overview
Table 372 Abbvie: Products Offered
Table 373 Abbvie: Product Approvals, January 2021- August 2024
Table 374 Pfizer: Company Overview
Table 375 Pfizer: Product Pipeline
Table 376 Pfizer: Product Approvals, January 2021-August 2024
Table 377 Pfizer: Deals, January 2021-August 2024
Table 378 Pfizer: Other Developments, January 2021-August 2024
Table 379 Bausch Health Companies: Company Overview
Table 380 Bausch Health Companies: Products Offered
Table 381 Bausch Health Companies: Product Approvals, January 2021- August 2024
Table 382 Chiesi Farmaceutici: Company Overview
Table 383 Chiesi Farmaceutici: Products Offered
Table 384 Chiesi Farmaceutici: Deals, January 2021-August 2024
Table 385 Acadia Pharmaceuticals: Company Overview
Table 386 Acadia Pharmaceuticals: Products Offered
Table 387 Acadia Pharmaceuticals: Product Approvals, January 2021- August 2024
Table 388 Aurinia Pharmaceuticals: Company Overview
Table 389 Aurinia Pharmaceuticals: Products Offered
Table 390 Aurinia Pharmaceuticals: Product Approvals, January 2021- August 2024
Table 391 Merck & Co.: Company Overview
Table 392 Merck & Co.: Product Pipeline
Table 393 Merck & Co.: Other Developments, January 2021-August 2024
Table 394 Johnson & Johnson Services: Company Overview
Table 395 Johnson & Johnson Services: Product Pipeline
Table 396 Johnson & Johnson Services: Other Developments, January 2021- August 2024
Table 397 Swk Holdings: Company Overview
Table 398 Swk Holdings: Product Pipeline
Table 399 Swk Holdings: Other Developments, January 2021-August 2024
Table 400 R-Pharm Jsc: Company Overview
Table 401 R-Pharm Jsc: Products in Pipeline
Table 402 Entera Bio: Company Overview
Table 403 Entera Bio: Product Pipeline
Table 404 Entera Bio: Deals, January 2021-August 2024
Table 405 Entera Bio: Other Developments, January 2021-August 2024
Table 406 Proxima Concepts: Company Overview
Table 407 Proxima Concepts: Products in Pipeline